Stay updated on ImPRESS: Losartan Imaging Perfusion Clinical Trial
Sign up to get notified when there's something new on the ImPRESS: Losartan Imaging Perfusion Clinical Trial page.

Latest updates to the ImPRESS: Losartan Imaging Perfusion Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page now shows attribution lines for Kyrre Eeg Emblem and Oslo University Hospital and adds verification-related labels. It also includes new user guidance sections such as How to Read a Study Record, Common Questions, and How to Join a Study.SummaryDifference1%

- Check19 days agoChange DetectedThe page's revision metadata was updated to v3.5.5, replacing the previous v3.5.4. This reflects a new version of the page without altering its visible content.SummaryDifference0.1%

- Check41 days agoChange DetectedAn updated site revision number is shown, changing from v3.5.3 to v3.5.4. This is a minor platform release reflected in the page metadata and does not alter the study content.SummaryDifference0.1%

- Check55 days agoChange DetectedAdded publication citation: Lysvik EK, Tulipan AJ, Haakensen VD, Revheim MR, Emblem KE, Hjornevik T. Quantitative [18F]PSMA-1007 PET in Treatment Response Monitoring of Brain Metastases from Non-small Cell Lung Cancer. Mol Imaging Biol. 2026 Apr 23. Online ahead of print. Revision: v3.5.3.SummaryDifference0.1%

- Check69 days agoChange DetectedRevision: v3.5.2 is displayed, replacing the previous v3.5.0 revision label.SummaryDifference0.1%

- Check98 days agoChange DetectedSite revision updated from v3.4.3 to v3.5.0. No substantive changes to the study details or content were observed.SummaryDifference0.1%

Stay in the know with updates to ImPRESS: Losartan Imaging Perfusion Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ImPRESS: Losartan Imaging Perfusion Clinical Trial page.